Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-09-14

AUTHORS

L Zhou, X-D Liu, M Sun, X Zhang, P German, S Bai, Z Ding, N Tannir, C G Wood, S F Matin, J A Karam, P Tamboli, K Sircar, P Rao, E B Rankin, D A Laird, A G Hoang, C L Walker, A J Giaccia, E Jonasch

ABSTRACT

Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance to sunitinib, an antiangiogenic small molecule, and to exploit this mechanism therapeutically. We hypothesized that sunitinib-induced upregulation of the prometastatic MET and AXL receptors is associated with resistance to sunitinib and with more aggressive tumor behavior. In the present study, tissue microarrays containing sunitinib-treated and untreated RCC tissues were stained with MET and AXL antibodies. The low malignant RCC cell line 786-O was chronically treated with sunitinib and assayed for AXL, MET, epithelial–mesenchymal transition (EMT) protein expression and activation. Co-culture experiments were used to examine the effect of sunitinib pretreatment on endothelial cell growth. The effects of AXL and MET were evaluated in various cell-based models by short hairpin RNA or inhibition by cabozantinib, the multi-tyrosine kinases inhibitor that targets vascular endothelial growth factor receptor, MET and AXL. Xenograft mouse models tested the ability of cabozantinib to rescue sunitinib resistance. We demonstrated that increased AXL and MET expression was associated with inferior clinical outcome in patients. Chronic sunitinib treatment of RCC cell lines activated both AXL and MET, induced EMT-associated gene expression changes, including upregulation of Snail and β-catenin, and increased cell migration and invasion. Pretreatment with sunitinib enhanced angiogenesis in 786-0/human umbilical vein endothelial cell co-culture models. The suppression of AXL or MET expression and the inhibition of AXL and MET activation using cabozantinib both impaired chronic sunitinib treatment-induced prometastatic behavior in cell culture and rescued acquired resistance to sunitinib in xenograft models. In summary, chronic sunitinib treatment induces the activation of AXL and MET signaling and promotes prometastatic behavior and angiogenesis. The inhibition of AXL and MET activity may overcome resistance induced by prolonged sunitinib therapy in metastatic RCC. More... »

PAGES

2687-2697

Journal

TITLE

Oncogene

ISSUE

21

VOLUME

35

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/onc.2015.343

DOI

http://dx.doi.org/10.1038/onc.2015.343

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032987342

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26364599


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiogenesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Renal Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Nude", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Targeted Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-met", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrroles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor Protein-Tyrosine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sunitinib", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Xenograft Model Antitumor Assays", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "L", 
        "id": "sg:person.010364657117.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010364657117.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "X-D", 
        "id": "sg:person.0731762062.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731762062.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sun", 
        "givenName": "M", 
        "id": "sg:person.016240414407.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016240414407.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "X", 
        "id": "sg:person.0611744321.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611744321.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "German", 
        "givenName": "P", 
        "id": "sg:person.01127044233.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127044233.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bai", 
        "givenName": "S", 
        "id": "sg:person.01175157433.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175157433.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ding", 
        "givenName": "Z", 
        "id": "sg:person.011170235757.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011170235757.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tannir", 
        "givenName": "N", 
        "id": "sg:person.01004561122.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004561122.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wood", 
        "givenName": "C G", 
        "id": "sg:person.01040121722.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matin", 
        "givenName": "S F", 
        "id": "sg:person.0675713004.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675713004.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karam", 
        "givenName": "J A", 
        "id": "sg:person.01246663563.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246663563.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tamboli", 
        "givenName": "P", 
        "id": "sg:person.01274763446.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274763446.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sircar", 
        "givenName": "K", 
        "id": "sg:person.01213516075.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213516075.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rao", 
        "givenName": "P", 
        "id": "sg:person.013052615607.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013052615607.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.168010.e", 
          "name": [
            "Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rankin", 
        "givenName": "E B", 
        "id": "sg:person.01240670435.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240670435.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Exelixis Inc., South San Francisco, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.428377.d", 
          "name": [
            "Exelixis Inc., South San Francisco, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laird", 
        "givenName": "D A", 
        "id": "sg:person.01030410223.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030410223.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoang", 
        "givenName": "A G", 
        "id": "sg:person.01251207201.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251207201.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.412408.b", 
          "name": [
            "Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Walker", 
        "givenName": "C L", 
        "id": "sg:person.010214460117.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010214460117.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.168010.e", 
          "name": [
            "Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giaccia", 
        "givenName": "A J", 
        "id": "sg:person.01247276247.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247276247.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jonasch", 
        "givenName": "E", 
        "id": "sg:person.01172764022.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172764022.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrc3205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048356671", 
          "https://doi.org/10.1038/nrc3205"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm1261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036162157", 
          "https://doi.org/10.1038/nrm1261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2012.71", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035196942", 
          "https://doi.org/10.1038/nrclinonc.2012.71"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605366", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021752317", 
          "https://doi.org/10.1038/sj.bjc.6605366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2012.378", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029157397", 
          "https://doi.org/10.1038/onc.2012.378"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2045-824x-6-12", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033247976", 
          "https://doi.org/10.1186/2045-824x-6-12"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.2577", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025540052", 
          "https://doi.org/10.1038/nm.2577"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2013.487", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051495759", 
          "https://doi.org/10.1038/onc.2013.487"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2010.268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033325165", 
          "https://doi.org/10.1038/onc.2010.268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng.2330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012810656", 
          "https://doi.org/10.1038/ng.2330"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-09-14", 
    "datePublishedReg": "2015-09-14", 
    "description": "Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance to sunitinib, an antiangiogenic small molecule, and to exploit this mechanism therapeutically. We hypothesized that sunitinib-induced upregulation of the prometastatic MET and AXL receptors is associated with resistance to sunitinib and with more aggressive tumor behavior. In the present study, tissue microarrays containing sunitinib-treated and untreated RCC tissues were stained with MET and AXL antibodies. The low malignant RCC cell line 786-O was chronically treated with sunitinib and assayed for AXL, MET, epithelial\u2013mesenchymal transition (EMT) protein expression and activation. Co-culture experiments were used to examine the effect of sunitinib pretreatment on endothelial cell growth. The effects of AXL and MET were evaluated in various cell-based models by short hairpin RNA or inhibition by cabozantinib, the multi-tyrosine kinases inhibitor that targets vascular endothelial growth factor receptor, MET and AXL. Xenograft mouse models tested the ability of cabozantinib to rescue sunitinib resistance. We demonstrated that increased AXL and MET expression was associated with inferior clinical outcome in patients. Chronic sunitinib treatment of RCC cell lines activated both AXL and MET, induced EMT-associated gene expression changes, including upregulation of Snail and \u03b2-catenin, and increased cell migration and invasion. Pretreatment with sunitinib enhanced angiogenesis in 786-0/human umbilical vein endothelial cell co-culture models. The suppression of AXL or MET expression and the inhibition of AXL and MET activation using cabozantinib both impaired chronic sunitinib treatment-induced prometastatic behavior in cell culture and rescued acquired resistance to sunitinib in xenograft models. In summary, chronic sunitinib treatment induces the activation of AXL and MET signaling and promotes prometastatic behavior and angiogenesis. The inhibition of AXL and MET activity may overcome resistance induced by prolonged sunitinib therapy in metastatic RCC.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/onc.2015.343", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438826", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2435652", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.5054438", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2480762", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "21", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "35"
      }
    ], 
    "keywords": [
      "renal cell carcinoma", 
      "metastatic renal cell carcinoma", 
      "inhibition of AXL", 
      "prometastatic behavior", 
      "sunitinib treatment", 
      "cell carcinoma", 
      "epithelial-mesenchymal transition (EMT) protein expression", 
      "MET expression", 
      "multi-tyrosine kinase inhibitor", 
      "vascular endothelial growth factor receptor", 
      "suppression of AXL", 
      "inferior clinical outcomes", 
      "endothelial growth factor receptor", 
      "RCC cell lines 786", 
      "aggressive tumor behavior", 
      "antiangiogenic therapy resistance", 
      "upregulation of Snail", 
      "xenograft mouse model", 
      "activation of Axl", 
      "cell co-culture model", 
      "effect of Axl", 
      "RCC cell lines", 
      "growth factor receptor", 
      "sunitinib therapy", 
      "short hairpin RNA", 
      "co-culture model", 
      "sunitinib resistance", 
      "clinical outcomes", 
      "cell line 786", 
      "endothelial cell growth", 
      "mechanisms of resistance", 
      "co-culture experiments", 
      "antiangiogenic small molecule", 
      "tissue microarray", 
      "mouse model", 
      "xenograft model", 
      "tumor behavior", 
      "RCC tissues", 
      "therapy resistance", 
      "sunitinib", 
      "Axl receptor", 
      "MET activation", 
      "cabozantinib", 
      "Axl", 
      "enhanced angiogenesis", 
      "kinase inhibitors", 
      "protein expression", 
      "factor receptor", 
      "MET activity", 
      "\u03b2-catenin", 
      "MetS", 
      "hairpin RNA", 
      "gene expression changes", 
      "cell-based model", 
      "patients", 
      "carcinoma", 
      "cell lines", 
      "therapy", 
      "cell migration", 
      "inhibition", 
      "upregulation", 
      "receptors", 
      "angiogenesis", 
      "present study", 
      "activation", 
      "expression changes", 
      "cell growth", 
      "treatment", 
      "cell cultures", 
      "expression", 
      "pretreatment", 
      "antibodies", 
      "EMT", 
      "outcomes", 
      "resistance", 
      "inhibitors", 
      "invasion", 
      "tissue", 
      "study", 
      "effect", 
      "microarray", 
      "suppression", 
      "small molecules", 
      "mechanism", 
      "RNA", 
      "activity", 
      "summary", 
      "snails", 
      "changes", 
      "migration", 
      "culture", 
      "purpose", 
      "ability", 
      "lines", 
      "model", 
      "growth", 
      "molecules", 
      "behavior", 
      "experiments"
    ], 
    "name": "Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma", 
    "pagination": "2687-2697", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032987342"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/onc.2015.343"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26364599"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/onc.2015.343", 
      "https://app.dimensions.ai/details/publication/pub.1032987342"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_667.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/onc.2015.343"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/onc.2015.343'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/onc.2015.343'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/onc.2015.343'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/onc.2015.343'


 

This table displays all metadata directly associated to this object as RDF triples.

426 TRIPLES      21 PREDICATES      152 URIs      134 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/onc.2015.343 schema:about N0fe367732d8645d6a11a6da074e9b08d
2 N37125d2e7016427bb6dd8e168c9f1a9d
3 N42906c7d5e9e445ca2d0b988edd5beee
4 N78eae5994a1145af9e050f55b7fbc2dc
5 N979f7fcbf9874e5d84424e3877a48809
6 N97d93b1fe8e3440591427b1654a0fe6a
7 N9ef973ea5103484b8a6c62cd047ac298
8 Na3517ea9e4cc449fb069ba71c5d7ada4
9 Nace35d43b17742cf9d66e6f99ac90a36
10 Naff77cc1100744aa8910455d0e77a842
11 Nb41b46d03dc648de9c9a1b82a4978d03
12 Nc0f66c83c9c844f9a1e3b318bde00902
13 Nd71c9d7851554394b41513963d87ecd2
14 Nec145a5d18964c6699a69f5e14f2b530
15 Nf296246672284b96b76d07399625f69f
16 Nf7f3835d424e437db70d023e38852cd7
17 Nfb56c8530ab346629fb115abccce33df
18 Nffda5ae73def4629bdf8d4e9cf1fb22e
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author Nff6730c4ffff422898484cf2bf489f58
22 schema:citation sg:pub.10.1038/ng.2330
23 sg:pub.10.1038/nm.2577
24 sg:pub.10.1038/nrc3205
25 sg:pub.10.1038/nrclinonc.2012.71
26 sg:pub.10.1038/nrm1261
27 sg:pub.10.1038/onc.2010.268
28 sg:pub.10.1038/onc.2012.378
29 sg:pub.10.1038/onc.2013.487
30 sg:pub.10.1038/sj.bjc.6605366
31 sg:pub.10.1186/2045-824x-6-12
32 schema:datePublished 2015-09-14
33 schema:datePublishedReg 2015-09-14
34 schema:description Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance to sunitinib, an antiangiogenic small molecule, and to exploit this mechanism therapeutically. We hypothesized that sunitinib-induced upregulation of the prometastatic MET and AXL receptors is associated with resistance to sunitinib and with more aggressive tumor behavior. In the present study, tissue microarrays containing sunitinib-treated and untreated RCC tissues were stained with MET and AXL antibodies. The low malignant RCC cell line 786-O was chronically treated with sunitinib and assayed for AXL, MET, epithelial–mesenchymal transition (EMT) protein expression and activation. Co-culture experiments were used to examine the effect of sunitinib pretreatment on endothelial cell growth. The effects of AXL and MET were evaluated in various cell-based models by short hairpin RNA or inhibition by cabozantinib, the multi-tyrosine kinases inhibitor that targets vascular endothelial growth factor receptor, MET and AXL. Xenograft mouse models tested the ability of cabozantinib to rescue sunitinib resistance. We demonstrated that increased AXL and MET expression was associated with inferior clinical outcome in patients. Chronic sunitinib treatment of RCC cell lines activated both AXL and MET, induced EMT-associated gene expression changes, including upregulation of Snail and β-catenin, and increased cell migration and invasion. Pretreatment with sunitinib enhanced angiogenesis in 786-0/human umbilical vein endothelial cell co-culture models. The suppression of AXL or MET expression and the inhibition of AXL and MET activation using cabozantinib both impaired chronic sunitinib treatment-induced prometastatic behavior in cell culture and rescued acquired resistance to sunitinib in xenograft models. In summary, chronic sunitinib treatment induces the activation of AXL and MET signaling and promotes prometastatic behavior and angiogenesis. The inhibition of AXL and MET activity may overcome resistance induced by prolonged sunitinib therapy in metastatic RCC.
35 schema:genre article
36 schema:isAccessibleForFree true
37 schema:isPartOf N02c7f63882b446af94dee138226f56ce
38 N5d1a8415278d429eaded360263c866c9
39 sg:journal.1097543
40 schema:keywords Axl
41 Axl receptor
42 EMT
43 MET activation
44 MET activity
45 MET expression
46 MetS
47 RCC cell lines
48 RCC cell lines 786
49 RCC tissues
50 RNA
51 ability
52 activation
53 activation of Axl
54 activity
55 aggressive tumor behavior
56 angiogenesis
57 antiangiogenic small molecule
58 antiangiogenic therapy resistance
59 antibodies
60 behavior
61 cabozantinib
62 carcinoma
63 cell carcinoma
64 cell co-culture model
65 cell cultures
66 cell growth
67 cell line 786
68 cell lines
69 cell migration
70 cell-based model
71 changes
72 clinical outcomes
73 co-culture experiments
74 co-culture model
75 culture
76 effect
77 effect of Axl
78 endothelial cell growth
79 endothelial growth factor receptor
80 enhanced angiogenesis
81 epithelial-mesenchymal transition (EMT) protein expression
82 experiments
83 expression
84 expression changes
85 factor receptor
86 gene expression changes
87 growth
88 growth factor receptor
89 hairpin RNA
90 inferior clinical outcomes
91 inhibition
92 inhibition of AXL
93 inhibitors
94 invasion
95 kinase inhibitors
96 lines
97 mechanism
98 mechanisms of resistance
99 metastatic renal cell carcinoma
100 microarray
101 migration
102 model
103 molecules
104 mouse model
105 multi-tyrosine kinase inhibitor
106 outcomes
107 patients
108 present study
109 pretreatment
110 prometastatic behavior
111 protein expression
112 purpose
113 receptors
114 renal cell carcinoma
115 resistance
116 short hairpin RNA
117 small molecules
118 snails
119 study
120 summary
121 sunitinib
122 sunitinib resistance
123 sunitinib therapy
124 sunitinib treatment
125 suppression
126 suppression of AXL
127 therapy
128 therapy resistance
129 tissue
130 tissue microarray
131 treatment
132 tumor behavior
133 upregulation
134 upregulation of Snail
135 vascular endothelial growth factor receptor
136 xenograft model
137 xenograft mouse model
138 β-catenin
139 schema:name Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
140 schema:pagination 2687-2697
141 schema:productId N66cd694a942d495aa1b7140b183e60f5
142 N78fce8ab0ee4476a91e10228865e4248
143 Na218054cab764478a0284a5080a94129
144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032987342
145 https://doi.org/10.1038/onc.2015.343
146 schema:sdDatePublished 2022-09-02T15:58
147 schema:sdLicense https://scigraph.springernature.com/explorer/license/
148 schema:sdPublisher Nb51d7dd4d4434a9f8faa618808016c82
149 schema:url https://doi.org/10.1038/onc.2015.343
150 sgo:license sg:explorer/license/
151 sgo:sdDataset articles
152 rdf:type schema:ScholarlyArticle
153 N02c7f63882b446af94dee138226f56ce schema:issueNumber 21
154 rdf:type schema:PublicationIssue
155 N06cdb5f707e04a34a392bfdd90ded3e0 rdf:first sg:person.0675713004.57
156 rdf:rest N190e465789b3474ca03cfb99c71ddb1f
157 N08d7ba0a1e5c47f9b7c52aabfe7f6af0 rdf:first sg:person.01040121722.56
158 rdf:rest N06cdb5f707e04a34a392bfdd90ded3e0
159 N0fe367732d8645d6a11a6da074e9b08d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Cell Proliferation
161 rdf:type schema:DefinedTerm
162 N1067f9b69d174071a1c4d8fef9280965 rdf:first sg:person.01127044233.98
163 rdf:rest Nc2c0e554da2d4cd49ca9d115532fe33e
164 N190e465789b3474ca03cfb99c71ddb1f rdf:first sg:person.01246663563.08
165 rdf:rest Ne1130ee8b69848498394168f02be1b7a
166 N2c7a071d651240a795b178ee9a8fe5ee rdf:first sg:person.010214460117.81
167 rdf:rest N3583d91a4abf439ba72b0a0b4a1df7a6
168 N3583d91a4abf439ba72b0a0b4a1df7a6 rdf:first sg:person.01247276247.59
169 rdf:rest N521519b2aaf34b2c917c1bcca5f35930
170 N37125d2e7016427bb6dd8e168c9f1a9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Molecular Targeted Therapy
172 rdf:type schema:DefinedTerm
173 N42906c7d5e9e445ca2d0b988edd5beee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Xenograft Model Antitumor Assays
175 rdf:type schema:DefinedTerm
176 N450d2b8433ae49fba788fa8faa5b575e rdf:first sg:person.01213516075.77
177 rdf:rest N7622ddc1fdbd45d9930061b45092034e
178 N521519b2aaf34b2c917c1bcca5f35930 rdf:first sg:person.01172764022.37
179 rdf:rest rdf:nil
180 N5cd98552a83a48558f4c6decf3ef78be rdf:first sg:person.0731762062.24
181 rdf:rest N7dd839de072f4c0c9dd8bc81aecfe549
182 N5d1a8415278d429eaded360263c866c9 schema:volumeNumber 35
183 rdf:type schema:PublicationVolume
184 N66cd694a942d495aa1b7140b183e60f5 schema:name pubmed_id
185 schema:value 26364599
186 rdf:type schema:PropertyValue
187 N6ad58c1712fb451dbc601606e61a49ed rdf:first sg:person.01004561122.13
188 rdf:rest N08d7ba0a1e5c47f9b7c52aabfe7f6af0
189 N6ee8a5dc474f455cb9f14006c3542e47 rdf:first sg:person.011170235757.76
190 rdf:rest N6ad58c1712fb451dbc601606e61a49ed
191 N7622ddc1fdbd45d9930061b45092034e rdf:first sg:person.013052615607.71
192 rdf:rest Nac4cc9463fcb478281e89916052f00ea
193 N78eae5994a1145af9e050f55b7fbc2dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Carcinoma, Renal Cell
195 rdf:type schema:DefinedTerm
196 N78fce8ab0ee4476a91e10228865e4248 schema:name dimensions_id
197 schema:value pub.1032987342
198 rdf:type schema:PropertyValue
199 N7dd839de072f4c0c9dd8bc81aecfe549 rdf:first sg:person.016240414407.34
200 rdf:rest Ne80020abbf18421380364bccd574afd9
201 N979f7fcbf9874e5d84424e3877a48809 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Signal Transduction
203 rdf:type schema:DefinedTerm
204 N97d93b1fe8e3440591427b1654a0fe6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Angiogenesis Inhibitors
206 rdf:type schema:DefinedTerm
207 N9ef973ea5103484b8a6c62cd047ac298 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Humans
209 rdf:type schema:DefinedTerm
210 Na218054cab764478a0284a5080a94129 schema:name doi
211 schema:value 10.1038/onc.2015.343
212 rdf:type schema:PropertyValue
213 Na3517ea9e4cc449fb069ba71c5d7ada4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Pyrroles
215 rdf:type schema:DefinedTerm
216 Nac4cc9463fcb478281e89916052f00ea rdf:first sg:person.01240670435.72
217 rdf:rest Nf025a0e5f03c4f66b0bd7a10619fa174
218 Nace35d43b17742cf9d66e6f99ac90a36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
219 schema:name Proto-Oncogene Proteins c-met
220 rdf:type schema:DefinedTerm
221 Naff77cc1100744aa8910455d0e77a842 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
222 schema:name Mice, Nude
223 rdf:type schema:DefinedTerm
224 Nb41b46d03dc648de9c9a1b82a4978d03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
225 schema:name Indoles
226 rdf:type schema:DefinedTerm
227 Nb51d7dd4d4434a9f8faa618808016c82 schema:name Springer Nature - SN SciGraph project
228 rdf:type schema:Organization
229 Nc0f66c83c9c844f9a1e3b318bde00902 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
230 schema:name Sunitinib
231 rdf:type schema:DefinedTerm
232 Nc2c0e554da2d4cd49ca9d115532fe33e rdf:first sg:person.01175157433.29
233 rdf:rest N6ee8a5dc474f455cb9f14006c3542e47
234 Ncb70720774f84c0099fc054922f952f7 rdf:first sg:person.01251207201.22
235 rdf:rest N2c7a071d651240a795b178ee9a8fe5ee
236 Nd71c9d7851554394b41513963d87ecd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
237 schema:name Drug Resistance, Neoplasm
238 rdf:type schema:DefinedTerm
239 Ne1130ee8b69848498394168f02be1b7a rdf:first sg:person.01274763446.75
240 rdf:rest N450d2b8433ae49fba788fa8faa5b575e
241 Ne80020abbf18421380364bccd574afd9 rdf:first sg:person.0611744321.75
242 rdf:rest N1067f9b69d174071a1c4d8fef9280965
243 Nec145a5d18964c6699a69f5e14f2b530 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
244 schema:name Kidney Neoplasms
245 rdf:type schema:DefinedTerm
246 Nf025a0e5f03c4f66b0bd7a10619fa174 rdf:first sg:person.01030410223.98
247 rdf:rest Ncb70720774f84c0099fc054922f952f7
248 Nf296246672284b96b76d07399625f69f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
249 schema:name Proto-Oncogene Proteins
250 rdf:type schema:DefinedTerm
251 Nf7f3835d424e437db70d023e38852cd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
252 schema:name Receptor Protein-Tyrosine Kinases
253 rdf:type schema:DefinedTerm
254 Nfb56c8530ab346629fb115abccce33df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
255 schema:name Animals
256 rdf:type schema:DefinedTerm
257 Nff6730c4ffff422898484cf2bf489f58 rdf:first sg:person.010364657117.87
258 rdf:rest N5cd98552a83a48558f4c6decf3ef78be
259 Nffda5ae73def4629bdf8d4e9cf1fb22e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
260 schema:name Mice
261 rdf:type schema:DefinedTerm
262 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
263 schema:name Medical and Health Sciences
264 rdf:type schema:DefinedTerm
265 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
266 schema:name Oncology and Carcinogenesis
267 rdf:type schema:DefinedTerm
268 sg:grant.2435652 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2015.343
269 rdf:type schema:MonetaryGrant
270 sg:grant.2438826 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2015.343
271 rdf:type schema:MonetaryGrant
272 sg:grant.2480762 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2015.343
273 rdf:type schema:MonetaryGrant
274 sg:grant.5054438 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2015.343
275 rdf:type schema:MonetaryGrant
276 sg:journal.1097543 schema:issn 0950-9232
277 1476-5594
278 schema:name Oncogene
279 schema:publisher Springer Nature
280 rdf:type schema:Periodical
281 sg:person.01004561122.13 schema:affiliation grid-institutes:grid.240145.6
282 schema:familyName Tannir
283 schema:givenName N
284 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004561122.13
285 rdf:type schema:Person
286 sg:person.010214460117.81 schema:affiliation grid-institutes:grid.412408.b
287 schema:familyName Walker
288 schema:givenName C L
289 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010214460117.81
290 rdf:type schema:Person
291 sg:person.01030410223.98 schema:affiliation grid-institutes:grid.428377.d
292 schema:familyName Laird
293 schema:givenName D A
294 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030410223.98
295 rdf:type schema:Person
296 sg:person.010364657117.87 schema:affiliation grid-institutes:grid.240145.6
297 schema:familyName Zhou
298 schema:givenName L
299 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010364657117.87
300 rdf:type schema:Person
301 sg:person.01040121722.56 schema:affiliation grid-institutes:grid.240145.6
302 schema:familyName Wood
303 schema:givenName C G
304 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56
305 rdf:type schema:Person
306 sg:person.011170235757.76 schema:affiliation grid-institutes:grid.240145.6
307 schema:familyName Ding
308 schema:givenName Z
309 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011170235757.76
310 rdf:type schema:Person
311 sg:person.01127044233.98 schema:affiliation grid-institutes:grid.240145.6
312 schema:familyName German
313 schema:givenName P
314 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127044233.98
315 rdf:type schema:Person
316 sg:person.01172764022.37 schema:affiliation grid-institutes:grid.240145.6
317 schema:familyName Jonasch
318 schema:givenName E
319 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172764022.37
320 rdf:type schema:Person
321 sg:person.01175157433.29 schema:affiliation grid-institutes:grid.240145.6
322 schema:familyName Bai
323 schema:givenName S
324 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175157433.29
325 rdf:type schema:Person
326 sg:person.01213516075.77 schema:affiliation grid-institutes:grid.240145.6
327 schema:familyName Sircar
328 schema:givenName K
329 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213516075.77
330 rdf:type schema:Person
331 sg:person.01240670435.72 schema:affiliation grid-institutes:grid.168010.e
332 schema:familyName Rankin
333 schema:givenName E B
334 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240670435.72
335 rdf:type schema:Person
336 sg:person.01246663563.08 schema:affiliation grid-institutes:grid.240145.6
337 schema:familyName Karam
338 schema:givenName J A
339 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246663563.08
340 rdf:type schema:Person
341 sg:person.01247276247.59 schema:affiliation grid-institutes:grid.168010.e
342 schema:familyName Giaccia
343 schema:givenName A J
344 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247276247.59
345 rdf:type schema:Person
346 sg:person.01251207201.22 schema:affiliation grid-institutes:grid.240145.6
347 schema:familyName Hoang
348 schema:givenName A G
349 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251207201.22
350 rdf:type schema:Person
351 sg:person.01274763446.75 schema:affiliation grid-institutes:grid.240145.6
352 schema:familyName Tamboli
353 schema:givenName P
354 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274763446.75
355 rdf:type schema:Person
356 sg:person.013052615607.71 schema:affiliation grid-institutes:grid.240145.6
357 schema:familyName Rao
358 schema:givenName P
359 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013052615607.71
360 rdf:type schema:Person
361 sg:person.016240414407.34 schema:affiliation grid-institutes:grid.240145.6
362 schema:familyName Sun
363 schema:givenName M
364 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016240414407.34
365 rdf:type schema:Person
366 sg:person.0611744321.75 schema:affiliation grid-institutes:grid.240145.6
367 schema:familyName Zhang
368 schema:givenName X
369 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611744321.75
370 rdf:type schema:Person
371 sg:person.0675713004.57 schema:affiliation grid-institutes:grid.240145.6
372 schema:familyName Matin
373 schema:givenName S F
374 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675713004.57
375 rdf:type schema:Person
376 sg:person.0731762062.24 schema:affiliation grid-institutes:grid.240145.6
377 schema:familyName Liu
378 schema:givenName X-D
379 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731762062.24
380 rdf:type schema:Person
381 sg:pub.10.1038/ng.2330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012810656
382 https://doi.org/10.1038/ng.2330
383 rdf:type schema:CreativeWork
384 sg:pub.10.1038/nm.2577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025540052
385 https://doi.org/10.1038/nm.2577
386 rdf:type schema:CreativeWork
387 sg:pub.10.1038/nrc3205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048356671
388 https://doi.org/10.1038/nrc3205
389 rdf:type schema:CreativeWork
390 sg:pub.10.1038/nrclinonc.2012.71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035196942
391 https://doi.org/10.1038/nrclinonc.2012.71
392 rdf:type schema:CreativeWork
393 sg:pub.10.1038/nrm1261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036162157
394 https://doi.org/10.1038/nrm1261
395 rdf:type schema:CreativeWork
396 sg:pub.10.1038/onc.2010.268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033325165
397 https://doi.org/10.1038/onc.2010.268
398 rdf:type schema:CreativeWork
399 sg:pub.10.1038/onc.2012.378 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029157397
400 https://doi.org/10.1038/onc.2012.378
401 rdf:type schema:CreativeWork
402 sg:pub.10.1038/onc.2013.487 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051495759
403 https://doi.org/10.1038/onc.2013.487
404 rdf:type schema:CreativeWork
405 sg:pub.10.1038/sj.bjc.6605366 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021752317
406 https://doi.org/10.1038/sj.bjc.6605366
407 rdf:type schema:CreativeWork
408 sg:pub.10.1186/2045-824x-6-12 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033247976
409 https://doi.org/10.1186/2045-824x-6-12
410 rdf:type schema:CreativeWork
411 grid-institutes:grid.168010.e schema:alternateName Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
412 schema:name Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
413 rdf:type schema:Organization
414 grid-institutes:grid.240145.6 schema:alternateName Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
415 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
416 Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
417 schema:name Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
418 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
419 Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
420 rdf:type schema:Organization
421 grid-institutes:grid.412408.b schema:alternateName Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, USA
422 schema:name Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, USA
423 rdf:type schema:Organization
424 grid-institutes:grid.428377.d schema:alternateName Exelixis Inc., South San Francisco, CA, USA
425 schema:name Exelixis Inc., South San Francisco, CA, USA
426 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...